Last reviewed · How we verify
[14C-ETC-1002]
At a glance
| Generic name | [14C-ETC-1002] |
|---|
| Sponsor | Esperion Therapeutics, Inc. |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.